Skip to main content

Table 2 Baseline characteristics of patients with diabetes and dilated cardiomyopathy with or without retinopathy

From: Diabetic retinopathy is associated with diastolic dysfunction in type 2 diabetic patients with non-ischemic dilated cardiomyopathy

Variable DR group No DR group P value
No. of patients 29 17  
Age (years) 60.4 ± 9.3 61.8 ± 14.1 0.487
Male, N (%) 17 (59%) 12 (71%) 0.417
Body mass index (kg/m2) 23.5 ± 3.2 25.0 ± 3.0 0.136
Hypertension, N (%) 19 (66%) 9 (53%) 0.399
Laboratory profiles
 HbA1c (%) 7.9 ± 1.8 7.4 ± 2.1 0.230
 Creatinine (mg/dL) 3.1 ± 3.3 1.1 ± 0.5 0.007*
 eGFR (mL/min/1.73 m2) 43.1 ± 29.8 71.9 ± 25.1 0.003*
 Total cholesterol (mg/dL) 157.3 ± 36.2 190.8 ± 36.6 0.009*
 Triglycerides (mg/dL) 112.9 ± 55.1 163.6 ± 105.1 0.284
 HDL cholesterol (mg/dL) 41.7 ± 12.2 50.9 ± 16.5 0.049*
 LDL cholesterol (mg/dL) 88.7 ± 37.6 100.6 ± 36.8 0.468
Medication
 Anticoagulants 18 (62%) 14 (82%) 0.149
 β-Blockers 18 (62%) 8 (47%) 0.322
 ACEI/ARB 25 (86%) 15 (88%) 0.844
 CCB 1 (3%) 0 (0%) 0.439
 Diuretics 19 (66%) 9 (53%) 0.399
 Statins 11 (38%) 4 (24%) 0.315
 DPP4 inhibitors 5 (17%) 1 (6%) 0.270
 Metformin 7 (24%) 3 (18%) 0.606
 Sulfonylurea 10 (34%) 6 (35%) 0.956
  1. ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, CCB calcium channel blocker, DPP4 dipeptidyl peptidase 4, DR diabetic retinopathy, eGFR estimated glomerular filtration rate, HDL high-density lipoprotein, LDL low-density lipoprotein
  2. P < 0.05 by independent t test or Mann–Whitney test